Joint Ventures Recaps Influential EULAR Studies in SLE, RA, and More ByRihards Buss, MD,Jack Arnold, MBBS, MRCP, PhDJuly 16th 2026
UPSTAND: Characterizing Nociceptive Pain and Disease Burden in AxSpAByDenis Poddubnyy, MD, PhD, MScJune 17th 2026
OLINGUITO: Filgotinib Meets Phase 3 Primary Endpoint in r/nr-axSpA, With Xenofon Baraliakos, MD, PhDByXenofon Baraliakos, MD, PhDJune 8th 2026